Injections can also be beneficial to a patients mental health by improving mood and helping with focus
Market Opportunity : Major opportunities include oral GLP-1 innovations, combination therapies integrating GIP/GLP-1 pathways, improved affordability for emerging markets, expanding indications beyond diabetes and obesity, and partnerships to enhance manufacturing capacity, distribution, and long-term patient adherence
Side Effects Gastrointestinal symptoms, specifically nausea, vomiting, diarrhea, and constipation, are far and away the most frequently reported side effects associated with GLP1 receptor agonist use
The standard escalation protocol Most providers prescribing Belmar semaglutide follow a gradual dose escalation that mirrors the FDA-approved Wegovy protocol, though individual adjustments are common: Weeks 1 through 4: 0.25 mg once weekly
What to Expect in Our Semaglutide Program Step 1